Emergency Order Under the Act on the Safety of Regenerative Medicine
Overview
An investigation confirmed multiple occurrences of serious illnesses and other events suspected to be related to regenerative medicine provided for advanced cancer by ICVS Tokyo Clinic, a medical corporation. No report on these events had been submitted under Article 18 of the Act, and their causes remain unclear. The Ministry of Health, Labour and Welfare therefore ordered a temporary suspension of the covered medical care under Article 22. The Ministry is establishing the facts and investigating the causes, and accepts information about cases suspected of violating laws or raising concerns about patient protection.
Key points
- Under Article 22 of the Act, the covered institution was ordered to temporarily suspend the provision of regenerative medicine and take other measures.
- Serious illnesses and other events suspected to be related to the regenerative medicine provided occurred multiple times.
- The Ministry of Health, Labour and Welfare is investigating the causes and accepting information.
Overview
An investigation was conducted based on information submitted to the regenerative medicine information and reporting contact point. The subject was regenerative medicine using dendritic cells and activated lymphocytes for advanced cancer, provided by ICVS Tokyo Clinic, a medical corporation in Chiyoda City, Tokyo.
Impact
Because patients developed serious illnesses and other events and their causes are unclear, the order requires a temporary suspension of the covered regenerative medicine to prevent harm to public health from occurring or spreading.
Details
Multiple occurrences of serious illnesses and other events were confirmed. At present, no report concerning these events has been submitted under Article 18 of the Act on the Safety of Regenerative Medicine.
The order requires a temporary suspension and other measures concerning the provision of regenerative medicine using dendritic cells and activated lymphocytes for advanced cancer. The Ministry of Health, Labour and Welfare says it will establish the facts of the case and conduct a thorough investigation into the causes to ensure safety.
The Ministry of Health, Labour and Welfare accepts information and reports to ensure the safety and proper implementation of regenerative medicine. It invites people to check the instructions on the dedicated submission form and provide information about cases suspected of violating laws or raising concerns about patient protection.